![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, March 05, 2021 5:22:52 AM
Does VIP function as modulator in regions of the brain associated with anxiety and depression
https://www.nature.com/articles/s41598-020-80873-2
nature scientific reports articles Published: 14 January 2021
Vasoactive intestinal polypeptide plasma levels associated with affective symptoms and brain structure and function in healthy females
Rozalyn A. Simon, Nawroz Barazanji, Michael P. Jones, Olga Bednarska, Adriane Icenhour, Maria Engström, J. Paul Hamilton, Åsa V. Keita & Susanna Walter
Scientific Reports
volume 11, Article number: 1406 (2021) Cite this article
Abstract
Vasoactive intestinal polypeptide (VIP) is a neuroendocrine peptide distributed throughout the human body, including the CNS, where it is particularly abundant in brain regions associated with anxiety and depression. Based on earlier studies indicating that peripheral VIP may cross through the blood–brain barrier, we hypothesized plasma VIP levels to be associated with symptoms of anxiety and depression, as well as brain volume and resting-state functional connectivity in the amygdala, hippocampus, parahippocampus, and orbitofrontal cortex.
Plasma VIP concentrations and anxiety/depression symptoms were measured in 37 healthy females. Functional and structural magnetic resonance imaging were used to evaluate functional connectivity and brain volume respectively, and their associations with VIP concentrations within brain regions associated with anxiety and depression. Negative correlations were found between VIP levels and symptoms of anxiety (r?=?- 0.44, p?=?0.002) and depression (r?=?- 0.50, p?=?0.001). Functional connectivity demonstrated significant VIP-dependent positive associations between the amygdala seed region with both the right parahippocampus (t(33)?=?3.1, pFDR?=?0.02) and right lateral orbitofrontal cortex (OFC; t(33)?=?2.9, pFDR?=?0.02). Moreover, VIP concentrations were significantly, positively correlated with brain volume in the left amygdala (r?=?0.28, p?=?0.007) and left lateral OFC (r?=?0.29, p?=?0.004).
The present findings highlight a potential role for VIP in the neurobiology of affective symptoms.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM